Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "AREA[SponsorSearch](Luye Pharma Group Ltd.)"
Count: 45
Selected: 0
NCT IDTitle
NCT03785652Dose-Finding Clinical Trial to Evaluate the Efficacy and Safety of LY03005 Extended-release Tablets in the Treatment of Major Depressive Disorder (MDD)
NCT04045678A Multiple Ascending Dose Study With LY03003 in Patients With Early-stage Parkinson's Disease
NCT04044547A Study of LY03003 in Patients With Early-stage Parkinson's Disease
NCT04973735A Phase I Study of LY-CovMab Injection in Chinese Healthy Subjects
NCT03427853A Study to Evaluate the Denosumab in Healthy Adults
NCT04973722A Study to Evaluate LY06006 and Prolia in Healthy Adults
NCT04572698A Study to Compare LY09004 and Eylea in the Treatment of Wet Age-related Macular Degeneration(wAMD)
NCT05060406A Study to Evaluate the Efficacy and Safety of LY06006 in Postmenopausal Women With Osteoporosis at High Risk for Fracture
NCT04198636A Study to Evaluate LY01011 and Xgeva® in Healthy Adults
NCT03844438A Study Evaluating the Safety, Tolerability of LPM3480226 Tablets in Patients With Advanced Solid Tumors
NCT04572685Evaluate the PK of LY03010 Process 1 and Process 2 Drug Product vs INVEGA SUSTENNA After Intramuscular Injection in Schizophrenia Patients
NCT05321602Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder
NCT05238701A Dose-escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetic of LPM3770164 in Healthy Subjects
NCT05140512Pharmacokinetics, Pharmacodynamics and Safety of LY01005 in Patients With Prostate Cancer Compared to ZOLADEX®
NCT05110170Efficacy and Safety of LY01005 in Patients With Breast Cancer Compared to ZOLADEX®
NCT04922593Relative Bioavailability of LY03010 Compared to Listed Drug
NCT04859569Efficacy and Safety of LY01011 and Xgeva® in Patients With Bone Metastases From Solid Tumors
NCT04853407A Study to Evaluate the Efficacy and Safety of Ansofaxine Hydrochloride Extended-release Tablets in the Treatment of Major Depressive Disorder (MDD)
NCT04638491Safety Tolerability Pharmacokinetic and Preliminary Efficacy in Chinese Advanced Solid Tumors Patients
NCT04630860A Study to Evaluate the Pharmacokinetics and Safety of LY03003 in Patients With Advanced-stage PD
NCT04629404A Clinical Trial to Evaluate the Pharmacodynamics/Pharmacokinetics and Safety of LY03003 in Early PD Patients
NCT04627155A Study to Evaluate the Human Tolerance and Pharmacokinetics of LY03003
NCT04593511to Evaluate the Safety, Tolerability and Pharmacokinetics of Four Formulations of LY03009 in Healthy Volunteers
NCT04571164A Study to Evaluate the Effectiveness and Safety of LY03003 in Patients With Early Primary PD
NCT04563936Efficacy and Safety of LY01005 in Patients With Prostate Cancer Compared to ZOLADEX®
NCT04384666A Randomized, Open-Label, Crossover Study to Evaluate the Pharmacokinetic Profiles of Rotigotine After a Single Dose of LY03003 (28 mg) Versus After a Week of Daily NEUPRO® Transdermal Patch (4 mg Every 24 Hours) in Healthy Volunteers
NCT04381910Irinotecan Hydrochloride Liposome Injection (LY01610) For Small Cell Lung Cancer
NCT04088604Irinotecan Hydrochloride Liposome Injection (LY01610) For Advanced Solid Tumors
NCT03822065A Relative Bioavailability Food Effect Study of LY03005
NCT03751488A Study to Determine Pharmacokinetic Characteristics of LY03010 Versus INVEGA SUSTENNA® in Schizophrenia Patients
NCT03733574A Study of LY03005 vs Pristiq
NCT03733561A Study to Assess Pharmacokinetic Profiles of LY03003 and Neupro
NCT03589066Pharmacokinetic Study of LY03003 in Patients With Parkinson's Disease
NCT03533127A Study of LY01008 and Bevacizumab Combined With Paclitaxel and Carboplatin for Treatment of Naïve Subjects With Metastatic or Recurrent Nonsquamous Non-small Cell Lung Cancer
NCT03450109A Study to Assess LY01005 Versus Goserelin Comparator (ZOLADEX®) in Patients With Prostate Cancer
NCT03357796Relative Bioavailability (RBA) Study of LY03005 vs Pristiq®
NCT02988024Pilot BA Study of New LY03005 vs Pristiq
NCT02728947Pharmacokinetic Profile of Neupro Patch Administrated at 2 mg, 4 mg, 6 mg and 8 mg/Day Weekly in Patients With Early-stage Parkinson's Disease
NCT02603770Compare Pharmacokinetic(PK) Profiles of XZK vs Lovastatin in Healthy Male Volunteers
NCT02271412Multiple Ascending Dose Study in Healthy Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY03005
NCT02186769An Randomized Open-Label PK Study of LY03004 Compared to Risperdal® Consta® in Stable Patients With Schizophrenia or Schizoaffective Disorder
NCT02091388Bioavailability of LY03004 and Risperdal® Consta®
NCT02055300Safety, Tolerability and Pharmacokinetics Study of LY03005
NCT02055287Pharmacokinetic and Safety Study of LY03004 in Stable Patients With Schizophrenia or Schizoaffective Disorder
NCT02055274Pharmacokinetics and Safety Study of LY03003 in Patients With Early-stage Parkinson's Disease